0000313143-12-000022.txt : 20120328 0000313143-12-000022.hdr.sgml : 20120328 20120328155419 ACCESSION NUMBER: 0000313143-12-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120326 FILED AS OF DATE: 20120328 DATE AS OF CHANGE: 20120328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gordon Mikael CENTRAL INDEX KEY: 0001418808 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 12720644 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION INCORPORATED STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 400 WOOD RD CITY: BRAINTREE STATE: MA ZIP: 02184 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 4 1 edgardoc.xml PRIMARY DOCUMENT X0305 4 2012-03-26 0 0000313143 HAEMONETICS CORP HAE 0001418808 Gordon Mikael 400 WOOD ROAD BRAINTREE MA 02184 0 1 0 0 President, Global Markets Common Stock 2012-03-26 4 S 0 890.0 70.0 D 6838.0 D Non-Qualified Stock Option (right to buy) 52.94 2010-10-27 2016-10-27 Common Stock 19587.0 19587.0 D Non-Qualified Stock Option (right to buy) 54.55 2009-10-22 2015-10-22 Common Stock 15247.0 15247.0 D Non-Qualified Stock Option (right to buy) 54.99 2011-10-27 2017-10-27 Common Stock 18940.0 18940.0 D Non-Qualified Stock Option (right to buy) 55.14 2009-01-22 2015-01-22 Common Stock 18980.0 18980.0 D Non-Qualified Stock Option (right to buy) 61.34 2012-10-25 2018-10-25 Common Stock 17565.0 17565.0 D Pursuant to a 10b5-1 Plan. Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan. Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant. By: Susan M. Hanlon For: Mikael Gordon 2012-03-27